Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, Jiangsu, People's Republic of China.
State Key Laboratory of Natural Medicines, Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
BMC Cardiovasc Disord. 2021 Nov 8;21(1):531. doi: 10.1186/s12872-021-02336-4.
The purpose of this study was to examine the correlation between fasting blood glucose and new-onset hypertension and examine any synergistically effect modification with multiple risk factors.
We conducted post-hoc analyses of repeated-measures data in the original Dongzhi osteoporosis cohort study. In total, 3985 participants without hypertension aged 25-64 years were included in the current analyses. Generalized estimating equation models were used to assess the relationship between fasting blood glucose and risk of new-onset hypertension after adjusting for pertinent covariates and autocorrelations among siblings.
393 men (19.4%) and 398 women (20.3%) without hypertension at the baseline developed hypertension by the end of the study period. Compared to lower baseline fasting blood glucose levels (Q1-Q3: < 5.74 mmol/L; clinical cut points: < 5.6 mmol/L), higher baseline fasting blood glucose levels (Q4: ≥ 5.74 mmol/L; clinical cut points: ≥ 5.6 mmol/L and < 7.0 mmol/L) increased the risk of new-onset hypertension significantly [(OR: 1.54, 95% CI 1.19-1.98, P < 0.001); (OR: 1.38, 95% CI 1.09-1.75, P = 0.008)] in women. Additionally, a stronger significant association was found in women with elevated fasting blood glucose on risk of new-onset of hypertension with higher total cholesterol (≥ 5.2 mmol/L) [(OR: 2.76; 95% CI: (1.54, 4.96), P < 0.001)]. However, no association was found between fasting blood glucose and risk of new-onset hypertension in men.
High fasting blood glucose may be significantly associated with risk of new-onset hypertension in Chinese women, especially in women with higher total cholesterol. Further randomized studies are needed to confirm our findings.
本研究旨在探讨空腹血糖与新发高血压的相关性,并检验多种危险因素的协同作用修饰。
我们对原始冬至骨质疏松队列研究的重复测量数据进行了事后分析。共纳入 3985 名年龄在 25-64 岁、无高血压的参与者进行当前分析。使用广义估计方程模型来评估空腹血糖与新发生高血压风险之间的关系,同时调整了相关协变量和兄弟姐妹之间的自相关。
基线时无高血压的 393 名男性(19.4%)和 398 名女性(20.3%)在研究期末发生了高血压。与较低的基线空腹血糖水平(Q1-Q3:<5.74mmol/L;临床切点:<5.6mmol/L)相比,较高的基线空腹血糖水平(Q4:≥5.74mmol/L;临床切点:≥5.6mmol/L 且<7.0mmol/L)显著增加了新发高血压的风险[(OR:1.54,95%CI 1.19-1.98,P<0.001);(OR:1.38,95%CI 1.09-1.75,P=0.008)]在女性中。此外,在空腹血糖升高且总胆固醇水平升高(≥5.2mmol/L)的女性中,新发高血压的风险与空腹血糖之间存在更强的显著相关性[(OR:2.76;95%CI:(1.54,4.96),P<0.001)]。然而,在男性中,空腹血糖与新发高血压风险之间无关联。
高空腹血糖可能与中国女性新发高血压风险显著相关,尤其是在总胆固醇水平较高的女性中。需要进一步的随机研究来证实我们的发现。